SCHEMBL627126

SCHEMBL627126

CCCCC(Oc1c(C)c(C)c2c(c1C)CCC(C)(CCCC(C)CCCC(C)C)O2)C(=O)O

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 4/20 0.69
MEN1 O00255 2/20 0.69
KMT2A Q03164 2/20 0.69
PDE4A P27815 1/20 0.69
PDE3A Q14432 1/20 0.69
GSTO1 P78417 2/20 0.66
PTPN1 P18031 1/20 0.66
TTPA P49638 3/20 0.62
LMNA P02545 3/20 0.62
MAPT P10636 2/20 0.62
GSTP1 P09211 1/20 0.62
USP2 O75604 1/20 0.62
THRB P10828 1/20 0.62
CYP2C9 P11712 1/20 0.62
CYP2C19 P33261 1/20 0.62
NR1I2 O75469 3/20 0.59
ALOX5 P09917 1/20 0.59
PGR P06401 1/20 0.49
AKT1 P31749 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL627140 0.97 PSEN1 (0.68) PSEN1MEN1KMT2APDE4APDE3A
SCHEMBL627939 0.95 PSEN1 (0.70) PSEN1MEN1KMT2APDE4APDE3A
SCHEMBL627979 0.93 PSEN1 (0.72) PSEN1MEN1KMT2APDE4APDE3A
SCHEMBL10074176 0.84 MEN1 (0.85) PSEN1MEN1KMT2APDE4APDE3A
SCHEMBL9679087 0.84 MEN1 (0.85) PSEN1MEN1KMT2APDE4APDE3A
SCHEMBL13189006 0.83 MEN1 (0.74) PSEN1MEN1KMT2APDE4APDE3A
SCHEMBL16522842 0.83 MEN1 (0.74) PSEN1MEN1KMT2APDE4APDE3A
SCHEMBL627592 0.83 GSTO1 (0.70) PSEN1MEN1KMT2APDE4APDE3A
SCHEMBL628409 0.83 MEN1 (0.63) PSEN1MEN1KMT2APDE4APDE3A
SCHEMBL19321939 0.83 MEN1 (0.70) PSEN1MEN1KMT2APDE4APDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461362-B2 Protein phosphatase 2A-activating agents THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-06-11 US disclosed
EP-2419414-A1 PROTEIN PHOSPHATASE 2A-ACTIVATING AGENTS The Ohio State University Research Foundation (US) 2012-02-22 EP disclosed
US-20100267673-A1 PROTEIN PHOSPHATASE 2A-ACTIVATING AGENTS THE OHIO SATE UNIVERSITY RESEARCH FOUNDATION (US) 2010-10-21 US disclosed
WO-2010120711-A1 PROTEIN PHOSPHATASE 2A-ACTIVATING AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2010-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267673-A1 PROTEIN PHOSPHATASE 2A-ACTIVATING AGENTS PPP2CA, PPP2R2A, PPP2R1A PSEN1 1965/4885MEN1 4219/4885KMT2A 1918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.